Literature DB >> 25455279

Improved accuracy of acute graft-versus-host disease staging among multiple centers.

John E Levine1, William J Hogan2, Andrew C Harris1, Mark R Litzow2, Yvonne A Efebera3, Steven M Devine3, Ran Reshef4, James L M Ferrara5.   

Abstract

The clinical staging of acute graft-versus-host disease (GVHD) varies significantly among bone marrow transplant (BMT) centers, but adherence to long-standing practices poses formidable barriers to standardization among centers. We have analyzed the sources of variability and developed a web-based remote data entry system that can be used by multiple centers simultaneously and that standardizes data collection in key areas. This user-friendly, intuitive interface resembles an online shopping site and eliminates error-prone entry of free text with drop-down menus and pop-up detailed guidance available at the point of data entry. Standardized documentation of symptoms and therapeutic response reduces errors in grade assignment and allows creation of confidence levels regarding the diagnosis. Early review and adjudication of borderline cases improves consistency of grading and further enhances consistency among centers. If this system achieves widespread use it may enhance the quality of data in multicenter trials to prevent and treat acute GVHD.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  BMT; GVHD; bone marrow transplant; data entry system; graft-versus-host disease; guidance; multiple centers; online; staging; standardization; web

Mesh:

Year:  2014        PMID: 25455279      PMCID: PMC4381784          DOI: 10.1016/j.beha.2014.10.011

Source DB:  PubMed          Journal:  Best Pract Res Clin Haematol        ISSN: 1521-6926            Impact factor:   3.020


  9 in total

1.  Risk factors for acute GVHD and survival after hematopoietic cell transplantation.

Authors:  Madan Jagasia; Mukta Arora; Mary E D Flowers; Nelson J Chao; Philip L McCarthy; Corey S Cutler; Alvaro Urbano-Ispizua; Steven Z Pavletic; Michael D Haagenson; Mei-Jie Zhang; Joseph H Antin; Brian J Bolwell; Christopher Bredeson; Jean-Yves Cahn; Mitchell Cairo; Robert Peter Gale; Vikas Gupta; Stephanie J Lee; Mark Litzow; Daniel J Weisdorf; Mary M Horowitz; Theresa Hahn
Journal:  Blood       Date:  2011-10-18       Impact factor: 22.113

2.  The clinical diagnosis of acute graft-versus-host disease: a diversity of views amongst marrow transplant centers.

Authors:  K Atkinson; M M Horowitz; J C Biggs; R P Gale; A A Rimm; M M Bortin
Journal:  Bone Marrow Transplant       Date:  1988-01       Impact factor: 5.483

3.  IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade.

Authors:  P A Rowlings; D Przepiorka; J P Klein; R P Gale; J R Passweg; P J Henslee-Downey; J Y Cahn; S Calderwood; A Gratwohl; G Socié; M M Abecasis; K A Sobocinski; M J Zhang; M M Horowitz
Journal:  Br J Haematol       Date:  1997-06       Impact factor: 6.998

4.  Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Transplant Clinical Trials Network.

Authors:  Amin M Alousi; Daniel J Weisdorf; Brent R Logan; Javier Bolaños-Meade; Shelly Carter; Nancy Difronzo; Marcelo Pasquini; Steven C Goldstein; Vincent T Ho; Brandon Hayes-Lattin; John R Wingard; Mary M Horowitz; John E Levine
Journal:  Blood       Date:  2009-05-14       Impact factor: 22.113

5.  Prospective grading of graft-versus-host disease after unrelated donor marrow transplantation: a grading algorithm versus blinded expert panel review.

Authors:  Daniel J Weisdorf; David Hurd; Shelly Carter; Craig Howe; Lee Ann Jensen; John Wagner; Don Stablein; John Thompson; Nancy A Kernan
Journal:  Biol Blood Marrow Transplant       Date:  2003-08       Impact factor: 5.742

6.  Increasingly frequent diagnosis of acute gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation.

Authors:  Paul J Martin; George B McDonald; Jean E Sanders; Claudio Anasetti; Frederick R Appelbaum; H Joachim Deeg; Richard A Nash; Effie W Petersdorf; John A Hansen; Rainer Storb
Journal:  Biol Blood Marrow Transplant       Date:  2004-05       Impact factor: 5.742

7.  Longitudinal assessment of morbidity and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation: retrospective analysis of a multicenter phase III study.

Authors:  Fabrizio Carnevale-Schianca; Wendy Leisenring; Paul J Martin; Terry Furlong; Gary Schoch; Claudio Anasetti; Frederick R Appelbaum; Paul A Carpenter; H Joachim Deeg; Hans-Peter Kiem; Rainer Storb; George B McDonald; Richard A Nash
Journal:  Biol Blood Marrow Transplant       Date:  2009-06       Impact factor: 5.742

Review 8.  1994 Consensus Conference on Acute GVHD Grading.

Authors:  D Przepiorka; D Weisdorf; P Martin; H G Klingemann; P Beatty; J Hows; E D Thomas
Journal:  Bone Marrow Transplant       Date:  1995-06       Impact factor: 5.483

9.  A randomized phase II trial comparing tacrolimus and mycophenolate mofetil to tacrolimus and methotrexate for acute graft-versus-host disease prophylaxis.

Authors:  Janelle Perkins; Teresa Field; Jongphil Kim; Mohamed A Kharfan-Dabaja; Hugo Fernandez; Ernesto Ayala; Lia Perez; Mian Xu; Melissa Alsina; Leonel Ochoa; Daniel Sullivan; William Janssen; Claudio Anasetti
Journal:  Biol Blood Marrow Transplant       Date:  2010-01-25       Impact factor: 5.742

  9 in total
  11 in total

1.  eGVHD App: a new tool to improve graft-versus-host disease assessment.

Authors:  Marie Therese Rubio
Journal:  Haematologica       Date:  2018-10       Impact factor: 9.941

2.  Good responses but high TRM in adult patients after MSC therapy for GvHD.

Authors:  U Salmenniemi; M Itälä-Remes; J Nystedt; M Putkonen; R Niittyvuopio; K Vettenranta; M Korhonen
Journal:  Bone Marrow Transplant       Date:  2016-12-12       Impact factor: 5.483

3.  A prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre study.

Authors:  John E Levine; Thomas M Braun; Andrew C Harris; Ernst Holler; Austin Taylor; Holly Miller; John Magenau; Daniel J Weisdorf; Vincent T Ho; Javier Bolaños-Meade; Amin M Alousi; James L M Ferrara
Journal:  Lancet Haematol       Date:  2014-12-23       Impact factor: 18.959

Review 4.  Acute GVHD: think before you treat.

Authors:  Laura F Newell; Shernan G Holtan
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

5.  International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium.

Authors:  Andrew C Harris; Rachel Young; Steven Devine; William J Hogan; Francis Ayuk; Udomsak Bunworasate; Chantiya Chanswangphuwana; Yvonne A Efebera; Ernst Holler; Mark Litzow; Rainer Ordemann; Muna Qayed; Anne S Renteria; Ran Reshef; Matthias Wölfl; Yi-Bin Chen; Steven Goldstein; Madan Jagasia; Franco Locatelli; Stephan Mielke; David Porter; Tal Schechter; Zhanna Shekhovtsova; James L M Ferrara; John E Levine
Journal:  Biol Blood Marrow Transplant       Date:  2015-09-16       Impact factor: 5.742

6.  Atorvastatin for the Prophylaxis of Acute Graft-versus-Host Disease in Patients Undergoing HLA-Matched Related Donor Allogeneic Hematopoietic Stem Cell Transplantation (allo-HCT).

Authors:  Yvonne A Efebera; Susan Geyer; Leslie Andritsos; Sumithira Vasu; Samantha Jaglowski; Anissa Bingman; William Blum; Rebecca Klisovic; Craig C Hofmeister; Don M Benson; Sam Penza; Patrick Elder; Katie Cortright; Rhonda Kitzler; Kevin Coombes; Lynn O'Donnell; Beth Daneault; Hillary Bradbury; Jianying Zhang; Xilin Chen; Sabrina Garman; Parvathi Ranganathan; Xueyan Yu; Jessica Hofstetter; Jianhua Yu; Ramiro Garzon; Scott R Scrape; Gerard Lozanski; Steven M Devine
Journal:  Biol Blood Marrow Transplant       Date:  2015-08-06       Impact factor: 5.742

7.  Long-Term Stable Mixed Chimerism after Hematopoietic Stem Cell Transplantation in Patients with Non-Malignant Disease, Shall We Be Tolerant?

Authors:  Arwen Stikvoort; Mikael Sundin; Mehmet Uzunel; Jens Gertow; Berit Sundberg; Marie Schaffer; Jonas Mattsson; Michael Uhlin
Journal:  PLoS One       Date:  2016-05-06       Impact factor: 3.240

8.  EBMT-NIH-CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment.

Authors:  Helene M Schoemans; Stephanie J Lee; James L Ferrara; Daniel Wolff; John E Levine; Kirk R Schultz; Bronwen E Shaw; Mary E Flowers; Tapani Ruutu; Hildegard Greinix; Ernst Holler; Grzegorz Basak; Rafael F Duarte; Steven Z Pavletic
Journal:  Bone Marrow Transplant       Date:  2018-06-05       Impact factor: 5.483

9.  Combining Flow and Mass Cytometry in the Search for Biomarkers in Chronic Graft-versus-Host Disease.

Authors:  Arwen Stikvoort; Yang Chen; Emelie Rådestad; Johan Törlén; Tadepally Lakshmikanth; Andreas Björklund; Jaromir Mikes; Adnane Achour; Jens Gertow; Berit Sundberg; Mats Remberger; Mikael Sundin; Jonas Mattsson; Petter Brodin; Michael Uhlin
Journal:  Front Immunol       Date:  2017-06-19       Impact factor: 7.561

10.  The eGVHD App has the potential to improve the accuracy of graft-versus-host disease assessment: a multicenter randomized controlled trial.

Authors:  Helene M Schoemans; Kathy Goris; Raf Van Durm; Steffen Fieuws; Sabina De Geest; Steven Z Pavletic; Annie Im; Daniel Wolff; Stephanie J Lee; Hildegard Greinix; Rafael F Duarte; Xavier Poiré; Dominik Selleslag; Philippe Lewalle; Tessa Kerre; Carlos Graux; Frédéric Baron; Johan A Maertens; Fabienne Dobbels
Journal:  Haematologica       Date:  2018-06-14       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.